Medexus Pharmaceuticals Inc's market cap is currently C$99.35M. The company's EPS TTM is C$0.199; its P/E ratio is 15.51; Medexus Pharmaceuticals Inc is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is C$-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	C$ 113.05M	C$ 108.10M	C$ 76.70M	C$ 79.66M	C$ 52.43M
Gross Profit	C$ 59.51M	C$ 60.04M	C$ 37.93M	C$ 42.01M	C$ 29.44M
Operating Income	C$ 10.79M	C$ 7.61M	C$ -15.00M	C$ -1.38M	-
EBITDA	C$ 19.28M	C$ 14.65M	C$ 15.16M	C$ -23.61M	C$ 7.04M
Net Income	C$ -214.00K	C$ 1.22M	C$ -2.88M	C$ -28.26M	-
Balance Sheet
Cash & Short-Term Investments	C$ 5.25M	C$ 13.07M	C$ 10.02M	C$ 18.70M	C$ 5.23M
Total Assets	C$ 155.73M	C$ 161.33M	C$ 139.22M	C$ 148.51M	C$ 122.81M
Total Debt	C$ 49.90M	C$ 70.08M	C$ 54.86M	C$ 44.87M	C$ 38.81M
Net Debt	C$ 44.64M	C$ 57.01M	C$ 44.84M	C$ 26.17M	C$ 33.58M
Total Liabilities	C$ 125.41M	C$ 138.88M	C$ 121.43M	C$ 130.50M	C$ 98.53M
Stockholders' Equity	C$ 30.32M	C$ 22.45M	C$ 17.79M	C$ 18.02M	C$ 24.28M
Cash Flow
Free Cash Flow	C$ 18.45M	C$ -1.81M	C$ -8.89M	C$ -5.72M	-
Operating Cash Flow	C$ 18.71M	C$ -1.44M	C$ -1.18M	C$ 5.04M	-
Investing Cash Flow	C$ -3.48M	C$ -1.72M	C$ -8.20M	C$ -11.70M	-
Financing Cash Flow	C$ -23.05M	C$ 6.41M	C$ 663.00K	C$ 18.68M	C$ 14.60M

Currency in CAD

Medexus Pharmaceuticals Inc Earnings and Revenue History

Income Statement >

Medexus Pharmaceuticals Inc Debt to Assets

Balance Sheet >

Medexus Pharmaceuticals Inc Cash Flow

Cash Flow >

Medexus Pharmaceuticals Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing